Topic
Adjuvant Therapy
1 Podcast on BackTable
Episode # 59 • 12 May 2026
Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most likely to shape HCC care? In this final episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi focus on the future of hepatocellular carcinoma beyond established PD-1/CTLA-4 regimens.
More on Adjuvant Therapy
Tumor Board Episode #59
May 12, 2026
with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...
Tumor Board Episode #55
Apr 14, 2026
with Dr. Shruti Patel, Dr. Jun Gong
How will the newest colorectal cancer trial results discussed at the 2026 ASCO GI Cancers Symposium in San Francisco...
240+ listens
Tumor Board Episode #49
Feb 24, 2026
with Dr. Bora Lim, Dr. Lindsay Peterson
Inflammatory breast cancer (IBC) is rare but highly aggressive, and often hides in plain sight. Rather than presenting...
190+ listens
Tumor Board Episode #36
Nov 18, 2025
with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung...
210+ listens
ENT Episode #270
Apr 21, 2026
with Dr. Joao Paulo Almeida, Dr. Zara Patel, Dr. Garret Choby, Dr. Satyan Sreenath
Could that routine epistaxis actually be the first sign of a challenging skull base tumor? This week’s episode of the...
1,300+ listens
Tumor Board Episode #54
Apr 7, 2026
with Dr. Tyler Stewart, Dr. Jun Gong
Don’t miss the “curative window”! This episode takes a closer look at how evolving perioperative strategies and...
210+ listens
VI Episode #595
Dec 5, 2025
with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung...
1,200+ listens
Tumor Board Episode #32
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri, Dr. Adam Luginbuhl
While the standard for adjuvant head and neck cancer treatment hasn't changed since 2004, a new trial using...
560+ listens
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.